People · Operator
Named in public records as an officer, director or promoter · active 2021–2025 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Prince Biotech, Inc. | — | Biotechnology | Series A | $10.0M | $27.8M | 2025 |
| Patient Focused Tele-Health Llc | — | Pharmaceuticals | Seed | $1.2M | $3.0M | 2021 |
Brian Huber at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brian Huber on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Douglas Prince | 1 | 2 |
| Jay Levy | 1 | 2 |
| Aaron Prince | 1 | 1 |
| Steve Sloate | 1 | 1 |
| Michael K. Miles | 1 | 1 |
| Delano Vincent | 1 | 1 |
| BRIAN J. HUBER | 1 | 1 |
| DELANO J. VINCENT | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.